NHS Greater Glasgow & Clyde Area Drug and Therapeutics Committee
Greater Glasgow and Clyde Medicines
Greater Glasgow and Clyde Medicines
Posted: July 29, 2019.
Category - Medicines Update
Updates from the MHRA for the second quarter of 2019 Drug Safety Update includes:
Posted: July 22, 2019.
Category - Medicines Update
Staff are asked to be aware of the following correction to the Initial Management of Neutropenic Sepsis in Adu...
Posted: June 24, 2019.
Category - Medicines Update
New Adult NHSGGC Guidelines now available on StaffNet
Posted: June 21, 2019.
Category - Medicines Update
The Adult Therapeutics Handbook content has now been updated. Several sections have had minor content updates. Other changes include:
Posted: June 17, 2019.
Category - Formulary Update
This post summarises the latest NHS Greater Glasgow and Clyde decisions relating to new medicines considered by the Area Drug and Therapeutics Committee (ADTC) and uses a nationally developed format specifically aimed for patients and the public.
For full details of the medicines included in this post that are available for use, including any restrictions on prescribing, please see the relevant entry in the GGC Formulary
Posted: May 24, 2019.
Category - Medicines Update
Targinact® (oxycodone with naloxone) prolonged release tablets are not recommended for use within NHS Scotland for the treatment of severe pain which can only be managed with opioid analgesics. Despite this, use in selected clinical areas o...
Posted: May 15, 2019.
Category - Medicines Update
Reports of adverse events associated with fluoroquinolone use prompted a recent EU safety review....
Posted: May 14, 2019.
Category - Medicines Update
A new GGC guideline on the Treatment of Iron Deficiency Anaemia (IDA) is now available on StaffNet
Posted: May 13, 2019.
Category - Medicines Update
Key messages In January 2019, the Faculty of Sexual and Reproductive Healthcare (FSRH) published updated clinical guidan...
Posted: May 07, 2019.
Category - Formulary Update
This post summarises the latest NHS Greater Glasgow and Clyde decisions relating to new medicines considered by the Area Drug and Therapeutics Committee (ADTC) and uses a nationally developed format specifically aimed for patients and the public.
For full details of the medicines included in this post that are available for use, including any restrictions on prescribing, please see the relevant entry in the GGC Formulary